ArticleBiomolecules & therapeutics2026

MHY5456, an FXR Agonist, Ameliorates Hepatic Steatosis and Fibrosis in a Mouse Model of MASLD.

Mi-Jeong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.